Researcher profile

Masaru Tanaka

Masaru Tanaka contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 13 - UnverifiedVerification L1Unclaimed author
2works
0followers
5topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2021arXiv

Bulk Production Augmentation Towards Explainable Melanoma Diagnosis

Although highly accurate automated diagnostic techniques for melanoma have been reported, the realization of a system capable of providing diagnostic evidence based on medical indices remains an open issue because of difficulties in obtaining reliable training data. In this paper, we propose bulk production augmentation (BPA) to generate high-quality, diverse pseudo-skin tumor images with the desired structural malignant features for additional training images from a limited number of labeled images. The proposed BPA acts as an effective data augmentation in constructing the feature detector for the atypical pigment network (APN), which is a key structure in melanoma diagnosis. Experiments show that training with images generated by our BPA largely boosts the APN detection performance by 20.0 percentage points in the area under the receiver operating characteristic curve, which is 11.5 to 13.7 points higher than that of conventional CycleGAN-based augmentations in AUC.

preprint2020arXiv

Antidepressant-like Effects of Neuropeptide SF (NPSF)

Neuropeptide SF (NPSF) is a member of RFamide neuropeptides that play diverse roles in central nervous system. Little is know about the effects of NPSF on brain functions. Antidepressant-like effect of NPSF was studied in modified mice FST. NPSF showed the antidepressant-like effects by decreasing the immobility time and increasing the climbing and swimming time. Furthermore, the involvement of the adrenergic, serotonergic, cholinergic or dopaminergic receptors in the antidepressant-like effect of NPSF was studied in modified mice FST. Mice were pretreated with a non-selective α-adrenergic receptor antagonist phenoxybenzamine, a \b{eta}-adrenergic receptor antagonist, propranolol, a non-selective 5-HT2 serotonergic receptor antagonist, cyproheptadine, nonselective muscarinic acetylcholine receptor antagonist, atropine, or D2, D3, D4 dopamine receptor antagonist, haloperidol. The present results confirmed that the antidepressant-like effect of NPSF is mediated, at least in part, by an interaction of the α-adrenergic, 5-HT2 serotonergic, muscarinic acetylcholine receptors and D2, D3, D4 dopamine receptor in a modified mouse FST.